lymphoma I and II Flashcards

1
Q

what is staging?

A
  • looking for where the tumor is

- this is done in hodgkin and non-hodgkin lymphoma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

some tests done in staging…

A

Labs: cbc, lytes, creatinin, BUN, LFTs
LDH: can be elevated in non-hodgkins
CT/PET: abd, pelvis, chest
BMB: bilateral

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

stage definitions I-IV

A

I - single lymph node
II - two or more lymph nodes on same side of diaphragm
III - two or more lymph nodes on different sides of diaphragm
IV - either multifocal involvement with one or more extra lymphatic site +/- associated lymph nodes OR involvement of extra lymphatic organ with distant nodal involvement

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

staging subclassifications

A

A - asymptomatic

B - either night sweats, fever, or greater than 10% weight loss in 6 months

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

what is meant by extra-lymphatic

A

tissue other than lymph nodes, thymus, spleen, Waldeyer’s ring, appendix, and Peyer’s patches

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

list some indolent lymphomas

A
  • CLL
  • follicular lymphoma
  • marginal zone lymphoma
  • MALT
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

list some aggressive lymphomas

A
  • ALL

- Burkitt’s lymphoma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

list some intermediately aggressive lymphomas

A
  • diffuse large B cell lymphoma
  • peripheral T cell lymphoma
  • mantle cell lymphoma
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

DLBCL who gets it?

A

adults and children, but mostly adults, median 64

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

DLBCL curability and percent presence in bone marrow?

A
  • curability 30-40%

- BM 15-20%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

DLBCL benign equivalent

A

large replicating cells of germinal center and paracortex

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

DLBCL pathophysiology

A

diffuse infiltration of lymph node, increased mitotic rate, necrosis may be present

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

DLBCL markers

A
  • CD19+, CD20+
  • possible: bcl-6 and/or bcl-2 expression
  • rearrangement of IgH, IgL chains
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

DLBCL subtypes of germinal center B cell origin, and which is better?

A

GCB - germinal center B cells (better survival)

ABC - activated B cell

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

characters of newly discovered highly aggressive DLBCL

A

over expression of “myc” oncogene and bcd-2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

DLBCL five point scale and rating

A

1) over 60
2) stage III or IV
3) elevated LDH
4) poor performance status
5) extra nodal involvement

0-1 - low
2 - low intermediate
3 - high intermediate
4-5 - high risk

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

DLBCL treatment

A
  • R-CHOP
  • usually chemo as well
  • autologous transplant only in refractory cases
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

what is R-CHOP?

A
  • rituximab
  • cyclophosphamide
  • adriamycin (anthracycline backbone)
  • vincristine
  • prednisone
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

rituximab is anti-CD….

A

CD20

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

what percent of NHL is follicular lymphoma?

A

22%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

who gets FL?

A

adults over 40, median 59

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

FL grades and aggressiveness

A

grade I - 5 or less large cells in follicle
grade II - 6-15 large cells
grade III - more than 15

grades I/II are considered indolent while grade III is treated as an intermediate large cell lymphoma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

FL presents at what stage?

A

III or IV

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

FL life expectancy

A

7-10 years but highly variable because there is an aggressive type

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
FL benign equivalent
small cleaved cell of germinal center
26
FL cell characteristics
- clumped chromatin - infrequent nucleolus - like small lymphocyte but irregular nuclear profile with nuclear folds
27
FL follicle characteristics
- maintains normal structure, but monotonous proliferation of one cell type
28
FL chromosomal translocation
- t(14;18) | - upregulates bcl-2 which is anti-apoptosis
29
FL immunophenotype
positive: CD19, CD20, CD10, bcl-2 negative: CD5, cyclin D1
30
clinical course of FL
indolent - slow growing with relapses
31
FLIPI scale
five point scale 1) over 60yo 2) elevated LDH 3) stage III or IV 4) greater than 4 LN sites 5) hemoglobin less than 12 3-5 - high 2 - intermediate 0-1 - low
32
FL - reasons to move from watchful waiting to treatment
1) Bulky, painful adenopathy 2) Organ involvement or impairment 3) B symptoms (severe) 4) Cytopenias due to bone marrow involvement 5) Autoimmune cytopenias (Idiopathic Thrombocytopenic Purpura; Autoimmune Hemolytic Anemia) 6) High FLIPI score
33
FL treatment
stages I and II - radiation alone is usually sufficient | stages III and IV - gentle chemo including rituximab (R-CVP)
34
MZL aggression?
indolent
35
three subtypes of MZL
1) extranodal marginal zone B cell lymphoma (MALT) 2) nodal marginal zone 3) splenic marginal zone lymphoma
36
MALT MZL can be in the....
GI tract, tear duct, salivary gland, etc
37
splenic MZL can be in the
spleen or bone marrow
38
MZL treatment
same as FL stages I and II - radiation alone is usually sufficient stages III and IV - gentle chemo including rituximab
39
MZL different from other indolent lymphomas because...
tends to be curable
40
MZL cell of origin
post germinal memory B cell that has the capacity to become a marginal zone cell.
41
MZL cell markers
positive: CD19, CD20 negative: CD5, CD10, cyclin D1
42
gastric MALT lymphoma symptoms similar to...
peptic ulcer
43
gastric MALT lymphoma is driven by...which can lead to which translocation?
- H. pylori | - t(11;18) which can produce a more aggressive MALT lymphoma
44
gastric MALT treatment
if H. pylori positive: antibiotics | if H. pylori negative: radiation therapy or chemotherapy is necessary. Rituxan has also been proven to be beneficial
45
hairy cell leukemia aggressiveness
indolent
46
why HCL called a leukemia?
it's in the blood and bone marrow but derived from a lymphocyte
47
HCL cell markers
positive: CD19, CD20 negative: CD5, CD10
48
HCL visualization
- "hairy" cytoplasmic projections | - in bone marrow, fried egg cytoplasm
49
HCL treatment
- purine analogue such as cladribine | - rituximab in relapse
50
Burkitt's lymphoma agressiveness
highly aggressive
51
who gets Burkitt's?
children, young adults, and immunocompromised
52
three types of Burkitt's
1) endemic - africa, EBV, children's jaws 2) immunocompromised - HIV/AIDS, 30% EBV positive, abdominal masses, marrow and nodal involvement, higher in cases with higher CD4 counts 3) sporadic - same as immunocomromised but in healthy children and young adults
53
Burkitt's benign equivalent
small non-cleaved cell of germinal center
54
Burkitt's pattern under a microscope
- starry sky - because of macrophages attracted by ineffective proliferation, want to phagocytose - this is all due to high mitotic rate with high failure
55
Burkitt's chromosomal translocation
- t(8;14) - causes up regulation of "myc" oncogene | - myc is major "on switch" of cell cycle and causes rapid proliferation
56
how long is survival with Burkitt's without treatment?
just a couples weeks
57
Burkitt's treatment
aggressive multi-drug chemo for 6-8 months
58
who gets mantle cell lymphoma?
adults, mean age 63
59
mantle cell lymphoma aggressiveness
appears indolent but acts intermediate to aggressive
60
mantle cell benign equivalent
lymphocyte of inner mantle zone
61
mantle cell pathology
t(11;14) upregulates bcl-1, increases cyclin D1 production
62
treatment of mantle cell
- poor response to therapies - 5 year survival is 30-50% - allogeneic and autologous transplants can be helpful
63
commonality of T cell lymphoma
only 20% of non-hodgkin lymphoma
64
where are most T cell lymphomas?
extranodal
65
if T cell lymphoma is nodal......
very bad, worse than any B cell lymphoma
66
common skin T cell lymphoma
mycosis fungoides
67
anaplastic large cell lymphoma is what type of lymphoma?
T cell
68
what is the translocation and protein in anapestic large cell lymphoma?
t(2;5) - ALK1
69
ALK1 vs non-ALK1 lymphoma
ALK1 positive has 93% survival rate while ALK1 negative has only 37% survival
70
3 basic characteristics of Hodgkin lymphoma
- less common than non-hodgkin - bimodal (adolescence and then again 6th decade) - spreads contiguously in lymphatics and doesn't often skip a region
71
what diagnoses hodgkin lymphoma?
reed sternberg cell, which is an altered B cell
72
hodgkin cell indicators
positive: CD15, CD30 negative: CD45
73
virus sometimes associated with hodgkin
EBV
74
4 subtypes of classical hodgkin lymphoma
1) nodular sclerosing 2) lymphocyte rich 3) lymphocyte depleted 4) mixed cellularity
75
nodular sclerosing classical hodgkin characteristics
- most common - neck and anterior mediastinal adenopathy in young females - fibrotic capsule and bands of subdividing tissue - lacunar varient reed-sternberg cells
76
lymphocyte rich classical hodgkin characteristics
- limited disease in neck of young adults | - "L and H" or "popcorn" RS cells
77
lymphocyte depleted classical hodgkin characteristics
- often retroperitoneal - aggressive - pleomorphic RS cells
78
mixed cellularity classical hodgkin characteristics
- aggressive - older patients - mononuclear RS cells - more of them
79
crude disease activity measure in hodgkins
ESR
80
hodgkin overall cure rate
over 80%
81
hodgkin treatment of stages I and II
abbreviated chemo and radiation, in stage one radiation alone may suffice
82
hodgkin treatment of stages III and IV
ABVD x 6, anthracycline backbone
83
what is considered primary refractory disease in hodgkin and what is the prognosis?
- grows through therapy or relapses in less than six months | - aggressive and often fatal
84
three stages of mycosis fungoides
three stage process of mycosis fungoides 1) patch 2) plaque 3) tumor
85
mycosis fungoides tumor stage
- mushroom shaped - predominant in groin, face, axilla, body folds - generalized lymphadenopathy - ulceration or necrosis
86
50% of those with CTCL die from....
staph or pseudomonas
87
sezary syndrome triad
1) erythroderma 2) leukemia (defining characteristic) 3) lymphadenopathy
88
sezary cells in peripheral blood
- large cells - cleaved nuclei - scant cytoplasm